Authors: | Yeung, K. S.; Gubili, J. |
Article Title: | Clinical guide to herb-drug interactions in oncology |
Abstract: | Cancer patients are increasingly using herbal supplements for relief of symptoms. However, there is a great potential for interactions with concurrent use of herbs and chemotherapy agents. Physicians should be aware of such interactions and encourage patients to discuss supplement use. |
Keywords: | clinical trial; review; angiogenesis inhibitor; bevacizumab; doxorubicin; antineoplastic agents; neoplasms; imatinib; unindexed drug; low drug dose; liver toxicity; pharmacodynamics; breast cancer; bleeding; prevalence; risk factors; clinical protocol; deep vein thrombosis; kidney failure; oncology; diet supplementation; irinotecan; lung embolism; drug distribution; warfarin; tamoxifen; platinum derivative; antioxidant; dietary supplements; herbaceous agent; ascorbic acid; traditional medicine; vinca alkaloid; herb drug interaction; drug absorption; taxane derivative; anthracycline derivative; turmeric; immunosuppressive agent; anticoagulant agent; drug elimination; vitamin k group; green tea extract; medicine, herbal; glycoprotein p; tea; herb-drug interactions; aristolochic acid; ginseng; silybum marianum extract; comfrey extract; hypericum perforatum extract; ginseng extract; chemotheraphy agents; herbal supplements; chamomile; furocoumarin; pyrrolizidine derivative; salvia miltiorrhiza extract; comfrey; coptis; kidney fibrosis; salvia miltiorrhiza |
Journal Title: | Journal of the Society for Integrative Oncology |
Volume: | 5 |
Issue: | 3 |
ISSN: | 1715-894X |
Publisher: | BC Decker |
Date Published: | 2007-06-01 |
Start Page: | 113 |
End Page: | 117 |
Language: | English |
DOI: | 10.2310/7200.2007.008 |
PUBMED: | 17761130 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Cited By (since 1996): 5" - "Export Date: 17 November 2011" - "Source: Scopus" |